Annual Meetings

2018 — Washington, DC

September 29—DSP and Board Meeting
September 30—CE Courses
October 1–October 3—Scientific Sessions

2017 — Berlin, Germany

September 23—DSP and Board Meeting
September 24—CE Courses
September 25–27—Scientific Sessions

2016 — Vancouver, Canada • September 18 to 21

Scientific topics Covered: Safety Pharmacology Across the Globe, Translational Cardiovascular Safety Pharmacology, Receptor Pharmacology, Advances in Technologies: In Vitro and In Silico Models, Practical Pharmacology, Personalized Medicine, Translational CNS and Respiratory Safety Pharmacology, State-of-the-Art Technologies and Methods, Translational Biomarkers: Bridging the Gap, Paediatric & Fetal Clinical Pharmacology, Regulatory Session, as well as SPS Oral Communications (from posters) and CSPT Trainee Presentations (from posters).

2015 — Prague, Czech Republic • September 28 to October 1

Featuring: Keynote by Prof. Dr. med. A.M. Das from Medizinische Hochschule Hannover in Hannover, Germany who spoke on Orphan Drugs in Inborn Errors of Metabolism – General Aspects and Clinical Vignettes, and Plenary Keynote on Wednesday, by David Sedmera, PhD from Charles University in Prague, who spoke on Drug Effects on the Developing Fetus: From Teratology Studies to Pharmacotherapy of Fetal Arrhythmias.

Scientific topics Covered: Central Nervous System—Issue Resolution, Cardiovascular—Cardiovascular Safety Assessment beyond the ECG, Translational Safety Biomarkers—From Preclinical to Clinical, Integrative Pharmacology—Case Studies in Diabetes and Pulmonary Arterial Hypertension, Central Nervous System—Sensory System Assessments in Safety Pharmacology, Cardiovascular—Translation of QT, Central Nervous System—Abuse Liability Potential: Current Advancements and Novel In Vitro Models—From Stem Cells to Human Tissues.

Regional Meetings


SPS Bay Area Regional Meeting: Filling Translational Gaps in Safety Assessment

Scientific Organizing Committee



Hosted by: Gilead
Location: Gilead, Foster City, CA
Date: Wednesday, November 14, 2018
Registration Time: 8:30 AM–08:50 AM
Meeting Time: 8:50 AM–5:30 PM
Networking: 5:30 PM–7:00 PM



SPS BOSTON REGIONAL MEETING: Emerging Topics on the Cutting Edge of Safety Pharmacology

Scientific Organizing Committee

AGENDA (coming soon)


Location: Vertex Pharmaceuticals, Boston, MA
Date: Wednesday, November 14, 2018

REGISTER (opening in August)


Award Opportunities

Distinguished Service Award

The Safety Pharmacology Society Distinguished Service Award (DSA) is an honor given to an individual who has substantially contributed to the field of Safety Pharmacology in one or more of the following areas: specific research achievements, champions of the field, lifelong contribution to the field, substantial specific contribution, visionary direction, regulatory decisions, science and technology of the field, education, mentorship in the field, collaboration between industry, academia, and regulatory.

Previous Distinguished Service Award Recipients

Junior Investigator Award

Eligible candidates for the Junior Investigator Award include students (undergraduate or graduate), technical staff, and junior scientists, postdoctoral fellows (< 5 years), and early career lab heads. The candidate should have less than 10 years experience in the field of safety pharmacology. Candidates may come from within academia, contract research organizations, pharmaceutical or biotechnology industry, government or engaged in preclinical research in safety pharmacology.

Exclusion criteria include previous Junior Travel Award winners, professors (undergraduate or graduate programs) and management personnel (e.g. laboratory head, principal investigator, or supervisor/mentor).

Previous Junior Investigator Award Recipients

Student Travel Award

Eligible candidates for the Student Travel Award include high school, undergraduate, or graduate students. Exclusion criteria include previous Student Travel Award winners.

Previous Student Travel Award Recipients